Liquid Biopsy Market to Hit USD Around 18,280.13 Million by
The global liquid biopsy market was estimated at USD 4,722.73 million in 2022 and is anticipated to hit around USD 18,280.13 million by 2032, registering a...
Source: globenewswire.com
Page 3 - Foundationone Liquid News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Foundationone Liquid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Foundationone Liquid Today - Breaking & Trending Today
Foundation Medicine, Merck KGaA to Collaborate on Companion Diagnostics
The companies will develop FoundationOne Liquid CDx and FoundationOne CDx as CDx tests in the US market for selected Merck KGaA marketed and pipeline treatments.
Source: genomeweb.com
Panitumumab Plus Trifluridine-Tipiracil Improves Outcomes in RAS Wild-type mCRC
The combination of panitumumab and standard-of-care trifluridine-tipiracil rechallenge delivered a progression-free survival benefit vs trifluridine-tipiracil alone in the third-line setting in patients with refractory RAS wild-type metastatic colorectal cancer, meeting the primary end point of the phase 2 VELO trial.
Source: onclive.com
Multicancer Screening Global Market Report 2023: Sector to Reach $7.78 Billion by 2032 at a 15% CAGR
/PRNewswire/ -- The "Multicancer Screening Market - A Global and Regional Analysis: Focus on Test Type, Technology, Sample, Method, Cancer Type, Application,...
Source: prnewswire.com
Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research
/PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Multicancer...
Source: prnewswire.com